Skip to main content
Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
1.540
+0.020 (1.32%)
Dec 20, 2024, 4:00 PM EST - Market closed

Nephros Revenue

Nephros had revenue of $3.52M in the quarter ending September 30, 2024, a decrease of -5.99%. This brings the company's revenue in the last twelve months to $13.55M, up 0.03% year-over-year. In the year 2023, Nephros had annual revenue of $14.24M with 42.74% growth.

Revenue (ttm)
$13.55M
Revenue Growth
+0.03%
P/S Ratio
1.19
Revenue / Employee
$436,968
Employees
31
Market Cap
16.24M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.24M4.26M42.74%
Dec 31, 20229.98M-242.00K-2.37%
Dec 31, 202110.22M1.66M19.34%
Dec 31, 20208.56M-1.77M-17.16%
Dec 31, 201910.33M4.65M81.71%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Oncology Institute 378.93M
bioAffinity Technologies 9.37M
Spruce Biosciences 7.10M
Synlogic 2.78M
Aprea Therapeutics 1.31M
Traws Pharma 226.00K
Revenue Rankings

NEPH News

More News